|
|
The “intestinal mechanism” of anti-diabetes drugs |
FENG Yuwei1, ZHANG Feng2,3,1, WANG Xuesong3,4,1, XIA Yanping2,3, HUA Jiao5,1, CAO Hong1,2,3,6 |
1. Wuxi School of Medicine, Jiangnan University, Wuxi 214122, Jiangsu Province, China; 2. Nutritional Department, Affiliated Hospital of Jiangnan University, Wuxi 214122, Jiangsu Province, China; 3. Clinical Assessment Center of Functional Food, Affiliated Hospital of Jiangnan University, Wuxi 214122, Jiangsu Province, China; 4. Department of Orthopedics, Affiliated Hospital of Jiangnan University, Wuxi 214122, Jiangsu Province, China; 5. Hospital Infection-Control Dep, Affiliated Hospital of Jiangnan University, Wuxi 214122, Jiangsu Province, China; 6. Department of Endocrinology, Affiliated Hospital of Jiangnan University, Wuxi 214122, Jiangsu Province, China |
|
|
Guide |
|
Abstract Diabetes is one of the most serious public health problems in China. Recently, growing evidence demonstrated that gut microbiota are closely involved in the onset and development of type 2 diabetes. Studies also indicated that anti-diabetic drugs can achieve the effect of lowering blood glucose by modulating gut microbiota to carry out “molecular dialogue” with the host. This paper summarized the recent publications related to the intestinal mechanism of anti-diabetic drugs.
|
Received: 05 March 2020
Published: 25 February 2021
|
|
Fund: |
Corresponding Authors:
CAO Hong
|
|
|
|
|
|
|